Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated greater occipital nerve methylprednisolone injections for chronic cluster headache
NL-OMON60096Phase 3Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cluster Headache (CH) comparing Methylprednisolone acetate GON injection with Placebo GON injection (2 arms). Primary endpoint: Retention rate. Started Aug 2024; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON60096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60096.